Tkaczuk, K. H. R., Rosenblatt, P., Scilla, K. A., Mehra, R., Jiang, Y., Hausner, P. F., Rao, G., Tait, N., Yue, B., Serrero, G. (2025). Phase 1 first-in-human clinical trial of AG01, a recombinant monoclonal antibody to progranulin/glycoprotein 88 (PGRN/GP88), to determine the safety, tolerability, pharmacokinetics, and preliminary anti-tumor response in subjects with advanced solid tumor malignancies.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.tps3180